About Index Trending news
Analyze
Pricing
SV Life Sciences

SV Life Sciences

Work at SV Life Sciences? Add yourself to this profile

SV Life Sciences

Life Sciences Venture Capital firm focused on selectively investing in biotech, medical devices and health-care services.

Elsewhere

Alexa global traffic share

Twitter followers

20 Mar 2017
$30,000,000
Venture capital (Series B)
SV Life Sciences, F-Prime Capital Partners, Johnson & Johnson, +2

British biotech Pulmocide raises £24m in bid to find treatment for deadly lung diseases

The Telegraph
+1
05 Jan 2017
Venture capital
Added by

Bardy Diagnostics nabs funding

PE Hub
04 Jan 2017
$8,000,000
Venture capital (Series A)

Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics

prnewswire
+1
16 Nov 2016
$34,000,000
Venture capital
Added by

LLR Partners Leads $34M Investment in SUN Behavioral Health | Business Wire

businesswire
21 Sep 2016
$33,200,000
Venture capital (Series A)
Imperial Innovations, SV Life Sciences, Merck Ventures, +3
Added by

Artios Pharma Raises $33.2M in Series A Funding

FinSMEs
01 Aug 2016
$11,890,000
Venture capital (Series A)

Aligned TeleHealth takes in $12 mln Series A

PE Hub
+1
06 Jan 2016
$15,000,000
Venture capital (Series B)
Added by

Deciphera Pharmaceuticals Increases Size of Series B Round to over $90M

FinSMEs
26 Aug 2015
$38,000,000
Venture capital (Series D)
Added by

ReShape Medical racks up $38 mln

PE Hub
15 Jan 2015
$12,400,000
Venture capital (Series A)
08 Dec 2014
09 May 2014
11 Dec 2013
$26,000,000
Venture capital (Series D)
Added by

Sutro Biopharma Secures $26M in Series D Financing

FinSMEs
14 Nov 2013
$32,400,000
Venture capital (Series B)
11 Sep 2013
$11,900,000
Debt financing
SV Life Sciences, Oxford Bioscience Partners, Forward Ventures
06 Feb 2013
23 Oct 2012
$15,000,000
Venture capital (Series C)
Added by

Obesity-Device Maker ReShape Medical Raises More Than $15M of $20M Series C

dowjones
03 Apr 2012
02 Apr 2012